Healthcare professionals' views about how pregnant women can benefit from using a closed-loop system: Qualitative study

Lawton, Julia, Rankin, David, Hartnell, Sara, Lee, Tara T. M. ORCID: https://orcid.org/0000-0001-6591-6421, Dover, Anna R., Reynolds, Rebecca M., Hovorka, Roman, Murphy, Helen R. and Hart, Ruth I. (2023) Healthcare professionals' views about how pregnant women can benefit from using a closed-loop system: Qualitative study. Diabetic Medicine, 40 (5). ISSN 0742-3071

[thumbnail of Diabetic Medicine - 2023 - Lawton - Healthcare professionals  views about how pregnant women can benefit from using a]
Preview
PDF (Diabetic Medicine - 2023 - Lawton - Healthcare professionals views about how pregnant women can benefit from using a) - Published Version
Available under License Creative Commons Attribution.

Download (304kB) | Preview

Abstract

Background Interest is growing in how closed-loop systems can support attainment of within-target glucose levels amongst pregnant women with type 1 diabetes. We explored healthcare professionals' views about how, and why, pregnant women benefitted from using the CamAPS FX system during the AiDAPT trial. Methods We interviewed 19 healthcare professionals who supported women using closed-loop during the trial. Our analysis focused on identifying descriptive and analytical themes relevant to clinical practice. Results Healthcare professionals highlighted clinical and quality-of-life benefits to using closed-loop in pregnancy; albeit, they attributed some of these to the continuous glucose monitoring component. They emphasised that the closed-loop was not a panacea and that, to gain maximum benefit, an effective collaboration between themselves, the woman and the closed-loop was needed. Optimal performance of the technology, as they further noted, also required women to interact with the system sufficiently, but not excessively; a requirement that they felt some women had found challenging. Even where healthcare professionals felt that this balance was not achieved, they suggested that women had still benefitted from using the system. Healthcare professionals reported difficulties predicting how specific women would engage with the technology. In light of their trial experiences, healthcare professionals favoured an inclusive approach to closed-loop rollout in routine clinical care. Conclusions Healthcare professionals recommended that closed-loop systems be offered to all pregnant women with type 1 diabetes in the future. Presenting closed-loop systems to pregnant women and healthcare teams as one pillar of a three-party collaboration may help promote optimal use.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health
Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Depositing User: LivePure Connector
Date Deposited: 14 May 2024 09:32
Last Modified: 14 May 2024 09:32
URI: https://ueaeprints.uea.ac.uk/id/eprint/95139
DOI: 10.1111/dme.15072

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item